Related Experiment Videos

Agents that activate protein kinase C reduce acetylcholine sensitivity in cultured myotubes

Insights

The tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA) reversibly decreased acetylcholine (ACh) sensitivity in cultured myotubes. This suggests protein kinase C activation may influence ACh receptor function.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Acetylcholine (ACh) is a key neurotransmitter in muscle function.
  • Protein kinase C (PKC) is a family of enzymes involved in cell signaling.
  • Tumor promoters like 12-O-tetradecanoyl-phorbol-13-acetate (TPA) can activate PKC.

Purpose of the Study:

  • To investigate the effect of TPA, a PKC activator, on acetylcholine sensitivity in cultured myotubes.
  • To explore the role of PKC in regulating neurotransmitter receptor function.

Main Methods:

  • Cultured chick and mouse myotubes were used.
  • Electrophysiological techniques (current- and voltage-clamping) were employed.
  • Cells were exposed to TPA, phosphatidylserine, and glyceryl dioleate.

Main Results:

  • TPA induced a reversible decrease in ACh sensitivity in 3-4-day-old chick myotubes.
  • This TPA-induced depression of ACh sensitivity was observed in older mouse myotubes only when co-treated with phosphatidylserine.
  • Glyceryl dioleate mimicked TPA's effects but with lower efficacy.

Conclusions:

  • Activation of protein kinase C may play a role in modulating the responsiveness of acetylcholine receptors.
  • These findings contribute to understanding the cellular mechanisms underlying neurotransmission and potential effects of signaling pathways on receptor function.

Related Concept Videos